From real patient stories to tips on living well, hear firsthand from people who have faced blood cancer.
We’ve also got the latest research and advocacy news, as well as stories from our wonderful fundraisers and donors. You can subscribe to our e-newsletters and event news here.
>In January 2020, Giles and wife Jacqui welcomed their baby daughter into the world. But just days later, Giles was hit with a shock blood cancer diagnosis that turned everything on its head.
Sophie was diagnosed with AML in 2019, aged 29. She had a stem cell transplant later the same year from an unrelated donor and has been in remission ever since. After leaning on her yoga and mindfulness practice heavily through her recovery, Sophie underwent her yoga teacher training and teaches in Adelaide. In this article the Leukaemia Foundation asked Sophie some questions about her experience with complementary therapies.
David Joske is a Clinical Haematologist at Sir Charles Gairdner Hospital in Perth Western Australia. He was Head of Department 1994 - 2012 and a Medical Co-Director 2017-2021. In this story David Joske talks to the Leukaemia Foundation about Complementary therapies.
Access to clinical trials of novel treatments, including immune checkpoint inhibitors and CAR T-cell therapy, could be a game changer for these patients, according to Dr Colm Keane. He is a clinical haematologist at the Princess Alexandra Hospital in Brisbane and a brain lymphoma researcher at the University of Queensland's Frazer Institute.
For Dr Sun Loo, being part of an innovative clinical trial is a perfect fit. It furthers research into her field of interest – measurable residual disease (MRD), and the blood cancer she is passionate about – acute myeloid leukaemia (AML).
Leukaemia researcher, Professor Andrew Wei hopes that clinical trials in the future will be routinely based on a new strategy of targeting measurable residual disease (MRD), commencing patients on treatment before clinical relapse.
Professor Daniel Tenen, who has devoted his research career to searching for a cure for cancer, has found an “ideal target”. It’s a gene called SALL4.
One of the first things Lyndell Wills did after being diagnosed with a blood cancer was to plan her dream holiday to South Africa.
This issue of preventable deaths is now being addressed along with other priority actions around national standards of care and consistent access to clinical best practice.
A timely and accurate blood cancer diagnosis is critical to clinical best practice.
Patients understand that clinical best practice care begins with an accurate and timely diagnosis.
When a patient is diagnosed with blood cancer, both the initial diagnosis and the resulting treatment and changes to daily life can feel overwhelming.
The Leukaemia Foundation works closely with healthcare professionals to connect people living with blood cancer with our services.
When talking to her patients, clinical haematologist and researcher Associate Professor Nada Hamad always considers their eligibility for a clinical trial.
Feelings of helplessness and confusion are common after losing a loved one and everything you need to do can be overwhelming.
